Wockhdardt Receives USFDA Nod

USFDA gives approval to Wockhardt for its ANDA (Abbreviated New Drug Application) for 0.1% ophthalmic solution of Olopatadine HCL, manufactured in Montreal, Canada, it is an eye drop and is a generic version of Patanol marketed in the US by Alcon, a subsidiary of Novartis.

Wockhardt Ltd is a biotechnology and pharmaceutical company, which is included manufacturing and marketing of biopharmaceuticalformulations and pharmaceutical, active pharmaceutical ingredient (APIs) and vaccines.

The company’s scrip opened at Rs 614.9 which  had a Rs 615.3 and  610.05 of high and low, 63871 NSE+BSE share were traded on the counter and Rs 6689.63cr is a current market cap.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.co
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔
Give a Missed Call for Free Trial - 09699997717 ✔